trenaxin 100mg/ml solution for injection
yung shin (philippines) inc, - tranexamic acid - solution for injection - 100mg/ml
tidact 150mg/ml solution for injection
yung shin (philippines) inc, - clindamycin (as phosphate) - solution for injection - 150mg/ml
nica 250mg/ml solution for injection
yung shin (philippines) inc, - amikacin (as sulfate) - solution for injection - 250mg/ml
embol 200mg/ ml solution for injection (im/iv)
yung shin (philippines), inc.; distributor: hi-technology pharmaceuticals, inc. - piracetam - solution for injection (im/iv) - 200mg/ ml
debtan 5 mg tablet
yung shin (philippines) inc.; distributor: philgen pharmaceuticals inc. - glibenclamide - tablet - 5 mg
granisetron hydrochloride injection, solution
yung shin pharmaceutical inc. co., ltd. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride injection usp is a serotonin-3 (5-ht3) receptor antagonist indicated for: - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high- dose cisplatin. - the prevention and treatment of postoperative nausea and vomiting in adults. as with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided during the postoperative period, granisetron hydrochloride injection is recommended even where the incidence of postoperative nausea and/or vomiting is low. granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. teratogenic effects pregnancy category b reproduction studies have been performed in pregnant rats at intravenous
granisetron hydrochloride injection, solution
yung shin pharmaceutical inc. co., ltd. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride injection, usp is a serotonin-3 (5-ht3 ) receptor antagonist indicated for: - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high- dose cisplatin. - the prevention and treatment of postoperative nausea and vomiting in adults. as with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided during the postoperative period, granisetron hydrochloride injection, usp is recommended even where the incidence of postoperative nausea and/or vomiting is low. granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. teratogenic effects pregnancy category b reproduction studies have been performed in pregnant rats at intra
decan 2 mg/ml solution for injection (im/iv)
n/a; importer: yung shin (philippines) inc.; distributor: yung shin (philippines) inc. - dexamethasone sodium phosphate - solution for injection (im/iv) - 2 mg/ml
danitin 25 mg/ml solution for injection (im/iv)
n/a; importer: yung shin (philippines), inc.; distributor: yung shin (philippines), inc. - ranitidine (as hydrochloride) - solution for injection (im/iv) - 25 mg/ml
tapimycin 4g/500 mg powder for injection (iv)
n/a; importer: yung shin (philippines), inc.; distributor: yung shin (philippines), inc. - piperacillin (as sodium) , tazobactam (as sodium) - powder for injection (iv) - 4g/500 mg